|
Leuprolide Acetate Clinical Trials
6 actively recruiting trials across 4 locations
Also known as: A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard +24 more
Pipeline
Phase 1: 1Phase 2: 3Phase 3: 2
Top Sponsors
- SWOG Cancer Research Network1
- Roswell Park Cancer Institute1
- Peking University First Hospital1
- ECOG-ACRIN Cancer Research Group1
- City of Hope Medical Center1
Indications
- Cancer6
- Stage IVB Prostate Cancer AJCC v84
- Metastatic Prostate Carcinoma2
- Stage IVA Prostate Cancer AJCC v82
- Stage IV Prostate Cancer AJCC v82
Anchorage, Alaska2 trials
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Site US10052
Phase 2
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Anchorage Associates in Radiation Medicine
Phase 3
Other1 trial
Gilbert, Arizona1 trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Banner MD Anderson Cancer Center
Phase 3
Duarte, California1 trial
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
City of Hope Medical Center
Phase 2
Buffalo, New York1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.